|
 |
| CASE REPORT |
|
| Year : 2011 | Volume
: 3
| Issue : 2 | Page : 98-101 |
|
|
Low-grade malignant proliferating pilar tumor simulating a squamous-cell carcinoma in an elderly female: A case report and immunohistochemical study
Harveen Kaur Gulati1, SD Deshmukh1, Mani Anand1, Vidya Morale1, Dilip Purushottamrao Pande2, Sandip Ekanath Jadhav2
1 Department of Pathology, Smt. Kashibai Navale Medical College & General Hospital, Narhe, Pune, Maharashtra, India
2 Department of Surgery, Smt. Kashibai Navale Medical College & General Hospital, Narhe, Pune, Maharashtra, India
| Date of Web Publication | 14-Dec-2011 |
Correspondence Address:
Harveen Kaur Gulati
Department of Pathology, Smt. Kashibai Navale Medical College and General Hospital, Narhe, Off Pune-Mumbai Bypass, Pune - 411041, Maharashtra
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0974-7753.90818
 Abstract | | |
A 65-year-old lady presented with an ulcerated lesion over the occipital region of nine-year duration, an incisional biopsy of which was reported as squamous-cell carcinoma. A wide local excision was performed and the tissue was sent for histopathological examination which revealed a low-grade malignant pilar tumor. Focal invasion and atypia were noted. Immunohistochemical (IHC) analysis revealed positivity for CD34 and calretinin immunomarkers favoring outer root sheath origin. Ki67 immunostains revealed a relatively low immunoreactivity indicating the low-grade nature of the tumor; however, p53 immunostain showed strong diffuse nuclear staining confirming the malignant nature of the tumor. Proliferating pilartumors (PPT) are rare tumors and less than 100 well-documented cases of malignant PPT have been reported so far in the literature.These tumors have been recently classified into benign, low- and high-grade malignant tumors and statistically significant difference was found in their biological behavior. However, we propose that IHC can be of immense value in assisting the subtyping of the tumor, so that the behavior and role of adjuvant therapy can be validated in future studies. Keywords: Proliferating pilar tumors, squamous-cell carcinoma, trichilemmal cyst
How to cite this article:
Gulati HK, Deshmukh S D, Anand M, Morale V, Pande DP, Jadhav SE. Low-grade malignant proliferating pilar tumor simulating a squamous-cell carcinoma in an elderly female: A case report and immunohistochemical study. Int J Trichol 2011;3:98-101 |
How to cite this URL:
Gulati HK, Deshmukh S D, Anand M, Morale V, Pande DP, Jadhav SE. Low-grade malignant proliferating pilar tumor simulating a squamous-cell carcinoma in an elderly female: A case report and immunohistochemical study. Int J Trichol [serial online] 2011 [cited 2023 Mar 25];3:98-101. Available from: https://www.ijtrichology.com/text.asp?2011/3/2/98/90818 |
| Introduction | |  |
Proliferating pilar tumor (PPT) was first described by Wilson-Jones in 1966 as "proliferating epidermoid cyst" and since then, a number of terms have been used to describe this lesion. [1] Some of them are proliferating trichilemmal cyst; giant hair matrix tumor; hydatidiform keratinous cyst; trichochlamydocarcinoma; and invasive hair matrix tumor, reflecting the disparity of interpretation about the nature and biological behavior of this entity. [2] These are rare tumors and less than 100 well-documented cases of malignant PPT have been reported so far in the literature. [3] We report here a case of low-grade malignant PPT which presented to us with an ulcerated scalp lesion with immunohistochemistry marker observation.
| Case Report | | |
A 65-year-old lady presented to our hospital with an ulcerated lesion over the occipital region.The swelling was present for the past nine years and was gradually increasing in size; however, it ulcerated after a trivial trauma one month back. On further probing, she gave a history of occasional itching and pain on the swelling over the past six months. An incisional biopsy done outside was reported as squamous-cell carcinoma. Local examination of the lesion revealed an ulceroproliferative lesion on the scalp measuring 2.5×1.5×1.0 cm. The swelling was fluctuant and was not fixed to the underlying bone. No lymph nodes were palpable in the neck. A wide local excision was performed and the tissue was sent for histopathological examination.
Grossly, the specimen measured 3.0×2.0×1.0 cm with a tumor measuring 2.0×1.5×1.0 cm. The skin over the swelling showed a small ulceration measuring 0.4 cm in diameter. On cut surface, the tumor was gray-white solid with areas of chalky white calcifications [Figure 1]. Section examined from the representative areas revealed epidermis showing focal ulceration with an underlying unencapsulated tumor. The tumor was composed of lobulated expansile masses of squamous cells with non-lamellated trichilemmal keratinization and patchy calcification [Figure 2]a. The squamous cells showed focal atypia in the form of nuclear enlargement, irregular nuclear membrane, hyperchromasia, and presence of few atypical mitoses [Figure 2]b. Periphery of the lobules showed invasion into the surrounding stroma with tongues and cords of malignant well-differentiated squamous cells. The interlobular and peripheral stroma showed mononuclear inflammatory infiltrate and foreign body giant cell reaction to keratin. No lymphovascular or perineural invasion was noted. The margins were free from tumor. With the above findings, a diagnosis of low-grade malignant pilar tumor was offered. Immunohistochemical (IHC) analysis revealed definite membrane positivity for CD34 in more than 70% of tumor cells, with normal vascular endothelial cells acting as internal control [Figure 3]a. CD34 along with calretinin [Figure 3]b immunopositivity favored outer root sheath origin of this pilar tumor over squamous-cell carcinoma. Furthermore, IHC staining was done for proliferation markers including Ki67 and p53. Ki67 immunostaining revealed a relatively low immunoreactivity showing staining of about 20% of the nuclei which was focal and present more toward the periphery of the lobules [Figure 3]c. However, p53 immunostain showed strong diffuse nuclear staining, confirming the malignant nature of the tumor [Figure 3]d. The patient was symptom free without any evidence of recurrence or metastasis after six months of follow-up after the surgery. | Figure 1: Photomicrograph showing solid gray-white tumor on cut surface, with areas of chalky white calcifications
Click here to view |
 | Figure 2: (a) Photomicrograph showing a tumor composed of lobulated expansile masses of squamous cells with non-lamellated trichilemmal keratinization. Also seen are nests of tumor cells infiltrating the stroma (H and E, ×100) (b) Photomicrograph showing squamous cells with atypia and presence of few atypical mitoses (H and E, ×400)
Click here to view |
 | Figure 3: Photomicrograph showing (a) CD34 membrane positive immunostaining with normal vascular endothelial cells acting as internal control. Also note the absence of the staining in surface epithelial cells (CD34, ×100). (b) Calretinin immunomarker showing positivity in and around the keratin within the squamous lobules highlighting the companion layer of outer root sheath (Calretinin, ×100). (c) Ki67 nuclear immunostaining with focal and peripheral reactivity (Ki67, ×100). (d) Immunostaining with p53 showing strong diffuse nuclear positivity (p53, ×100)
Click here to view |
| Discussion | | |
Pilar tumors are infrequent comprising only 0.1% of skin biopsies with the malignant counterpart being even rarer. [4] Since its recognition 45 years ago, PPTs were considered pseudoepitheliomatous hyperplasia or at best benign neoplasms which occurred on the scalp of elderly females. However, Saida et al. defined three stages of oncological transformation of trichilemmal tumors - trichilemmal cyst, the adenomatous stage; proliferating trichilemmal cyst, the epitheliomatous stage; and malignant PTT, the carcinomatous stage. [5] Various factors have been implicated in this oncological transformation which include trauma and inflammation. [6] Recently, a clinicopathological study of 76 cases divided PPT into three groups based on the degree of stromal invasion and the level of cytological atypia - benign, low- and high-grade malignant. [2] In this study, 20 cases of low-grade malignant tumors were studied and the mean age of presentation was found to be 64.1 years with a male to female ratio of 1:2. These tumors were present in head and neck region in 80% cases (mostly on the scalp), atypical sites being trunk and arm. Unlike the present case, most cases had a preoperative diagnosis of a benign lesion. However, it must be mentioned that 10% cases had a preoperative diagnosis of squamous-cell carcinoma, as in our case.
Although, the benign PPT exhibits characteristic histologic features, the need to differentiate malignant PPTs (which shows nodular and spindle subtypes) from other malignant tumors cannot be overemphasized. Various IHC markers have been used to highlight the outer sheath differentiation including CD34 and calretinin. [7],[8] CD34 expression strongly supports the outer root sheath origin of the tumor, although one case of CD34 negative malignant PPT has been reported. [7] Our case showed positivity in more than 70% of the cells as compared with only 1% and 20% positivity in one of the case series. [7] This may represent the degree of differentiation of the tumor from CD34 undifferentiated phenotype to CD34 positive differentiated phenotype. [7] Calretinin has recently been found to be the marker of companion layer of the outer root sheath and the positivity in our case confirms the origin. [8] Proliferation markers like Ki67 and p53 can assist in the stratification of these cases into the three-tier classification as suggested by Ye et al. [7],[9] Ki 67 was found to be only focally positive in <5% of the basal cells in trichilemmal cysts and benign PPT as compared with 30 to 40% cells in malignant PPT by one of the investigators,whereas our case showed Ki67 positivity in 20% of the cells. [7] The present case highlights the importance of these markers in the diagnosis and subtyping of this tumor.
All the 20 cases of low-grade malignant PPT in the large clinicopathological study underwent excision with a mean follow-up period of 29.5 years. [2] Three of the 20 cases of low-grade malignant PPT showed recurrence at three months, nine months, and two years, respectively, after the diagnosis and none showed evidence of metastasis. In contrast, the high-grade PPT showed an adverse outcome in 50% cases (25% recurred and 25% metastasized) and none of the benign PPTs showed evidence of recurrence after a mean follow-up period of 96 months. [2] Absence of any adjuvant therapy in previous series has been cited by one of the authors as a reason for adverse outcome in malignant PPTs. They have suggested adjuvant radiation therapy in malignant PPTs to achieve favorable locoregional control. [4] However, their case was a high-grade malignant subtype and the precise role of adjuvant therapy in low-grade tumors like ours needs further validation. The findings in the present case highlight the importance of IHC (especially, CD34, Ki67, and p53) in assisting the subtyping, so that the behavior and role of adjuvant therapy can be validated in future studies on this tumor.
| References | | |
| 1. | Jones EW. Proliferating epidermoid cysts. Arch Dermatol 1966;94:11-9. 
|
| 2. | Ye J, Nappi O, Swanson PE, Patterson JW, Wick MR. Proliferating Pilar Tumors: A Clinicopathologic study of 76 cases with a proposal for definition of benign and malignant variants. Am J ClinPathol 2004;122:566-74.
|
| 3. | Lopez- Rios F, Rodríguez-Peralto JL, Aguilar A, Hernández L, Gallego M.Proliferating trichilemmal cyst with focal invasion: Report of a case and a review of the literature. Am J Dermatopathol2000;22:183-7.
|
| 4. | Siddha M, Budrukkar A, Shet T, Deshpande M, Basu A, Patil N, et al. Malignant pilar tumor of the scalp: A case report and review of literature. J Cancer Res Ther 2007;3:240-3.
|
| 5. | Saida T, Ooharo K, Hori Y, Tsuchiya S. Development of a malignant proliferating trichilemmal cyst in a patient with multiple trichilemmal cysts. Dermatologica 1983;166:203-8.
|
| 6. | Fernandez SH. Malignant proliferating trichilemmal tumor: A case report. Malays J Pathol 1999;21:117-21.
|
| 7. | Chaichamnan K, Satayasoontorn K, Puttanupaab S, Attainsee A. Malignant proliferating trichilemmal tumors with CD34 expression. J Med Assoc Thai 2010;93;Suppl 6: S28-34.
|
| 8. | Gonzalez-Guerra E, Requena L, Kutzner H. Immunohistochemical study with calretenin in normal Hair follicles and tumors with Follicular differentiation. Actas Dermosifiliogr 2008;99:456-63.
|
| 9. | Fernández-Figueras MT, Casalots A, Puig L, Llatjós R, Ferrándiz C, Ariza A. Proliferating trichilemmal tumor: p53 immunoreactivity in association with p27 Kip1 over-expression indicates a low-grade carcinoma profile. Histopathology 2001;38:454-7.
|
[Figure 1], [Figure 2], [Figure 3]
| This article has been cited by | | 1 |
Systematic analysis and case series of the diagnosis and management of trichilemmal carcinoma |
|
| Jiachen Sun, Lihua Zhang, Minglu Xiao, Shiyi Li, Runkai Chen, Ying Li, Yuguang Yang | | Frontiers in Oncology. 2023; 12 | | [Pubmed] | [DOI] | | | 2 |
Proliferating Pilar Tumors Are Characterized by Recurrent 15q, 6q, and 6p22.2 Alterations |
|
| Grant M. Fischer, Neal I. Lindeman, Azra H. Ligon, Eleanor Russell-Goldman | | The American Journal of Dermatopathology. 2022; Publish Ah | | [Pubmed] | [DOI] | | | 3 |
Proliferating Pilar Tumors: Can Immunohistochemistry Differentiate Benign and Malignant Forms? |
|
| Pelin Yildiz, Ovgu Aydin Ulgen, Cansu Yol, Cuyan Demirkesen | | The American Journal of Dermatopathology. 2021; 43(3): 198 | | [Pubmed] | [DOI] | | | 4 |
Malignant Proliferating Trichilemmal Tumor of the Scalp: A Systematic Review |
|
| Muhammad Osto, Nathan Parry, Rafey Rehman, Uddin Ahmed, Darius Mehregan | | The American Journal of Dermatopathology. 2021; 43(12): 851 | | [Pubmed] | [DOI] | | | 5 |
Giant, Bleeding, and Ulcerating Proliferating Trichilemmal Cyst, With Delayed Treatment Due to Coronavirus Outbreak: A Case Report and Review of the Literature |
|
| Cecilie Mullerup Kiel, Preben Homøe | | Frontiers in Surgery. 2021; 8 | | [Pubmed] | [DOI] | | | 6 |
Malignant Proliferating Trichilemmal Tumor: A Subtle Presentation in an African American Woman and Review of Immunohistochemical Markers for This Rare Condition |
|
| Tejas P Joshi, Sharon Marchand, Jaime Tschen | | Cureus. 2021; | | [Pubmed] | [DOI] | | | 7 |
Recurrent trichilemmal cysts: Malignancy warning! [Recidiverende trichilemmale cystes: Cave maligniteit!] |
|
| Oduber, C.E. and Abdul-Hamid, M. and Van Der Velden, J.J.A.J. and Mosterd, K. and Kelleners-Smeets, N.W.J. | | Nederlands Tijdschrift voor Dermatologie en Venereologie. 2012; 22(6): 342-345 | | [Pubmed] | |
|
 |
|
|
|
